Repatha is not known to interact with alcohol. But Repatha and alcohol may cause some of the same side effects, including dizziness and headache. Drinking alcohol during your Repatha treatment ...

Many of the side effects reported in studies with Leqvio were also seen in studies of Repatha. But both drugs are known to cause some side effects that are not reported in studies of the other drug.

Vaccine side effects like soreness, fever, and fatigue scare some people out of getting their shots. Ask a doctor, though, and they’ll tell you these unpleasant symptoms have a silver lining ...

It can come with side effects, but not everyone who takes Ozempic will get every possible effect. This varies from person to person based on many things. But it’s good to have an idea of what ...

Hormonal birth control is a type of birth control that contains either the hormones estrogen and progestin or progestin alone. There are many different birth control ...

As with other drugs, Rexulti can cause side effects, such as weight gain, tiredness, and headache. Rexulti has boxed warnings. A boxed warning is the most serious warning from the Food and Drug ...

As with other drugs, Botox can cause side effects, which vary depending on the condition being treated. Note: This article focuses on Botox’s medical use, not its cosmetic use. You can see this ...

Do not take if the blister pack is damaged or missing. The most common side effects of vardenafil are listed below. These side effects may vary depending on the form of vardenafil prescribed.

The study wasn’t powered to assess effects on cardiovascular events, but there was some modest signs that Repatha produced better outcomes. An exploratory analysis revealed that positively ...

This is not to say that PPIs aren't without their challenges or limitations. While most of the side effects are mild and manageable, there are a number of adverse events which can occur with long-term ...

More than four years after Amgen’s cholesterol-lowering antibody Repatha was approved in the US, the company still can’t generate much sales momentum behind the product. Its latest gambit is ...